The Psychiatric Genomics Consortium (PGC) is the largest consortium in the history of
psychiatry. This global effort is dedicated to rapid progress and open science, and in the …

The primary aim of precision medicine is to tailor healthcare more closely to the needs of
individual patients. This requires progress in two areas: the development of more precise …

For over a century, psychiatric disorders have been defined by expert opinion and clinical
observation. The modern DSM has relied on a consensus of experts to define categorical …

Psychiatric disorders such as schizophrenia, bipolar disorder, major depressive disorder,
attention-deficit/hyperactivity disorder and autism spectrum disorder are common and result …

Genome-wide association studies have identified hundreds of robust genetic associations
underlying psychiatric disorders and provided important biological insights into disease …

Despite the complexities of schizophrenia, notable progress has been achieved in its
diagnosis and treatment over the last 25 years. In this article we review the genetic research …

Psychiatric genetics has made substantial progress in the last decade, providing new
insights into the genetic etiology of psychiatric disorders, and paving the way for precision …

The power and appeal of the molecular biology mantra,''DNA to RNA to protein,''to explicate
cell biology comes from its universal appearance and application in all species, from …

At the time DNA was discovered 50 years ago, psychiatric genetics was in a state of relative
dormancy, resulting from the misuse of genetic theories during the World War II era. As the …

Abstract The Genomic Psychiatry Cohort (GPC) is a longitudinal resource designed to
provide the necessary population‐based sample for large‐scale genomic studies, studies …